Affidea named diagnostics provider of the year

European provider of advanced diagnostics, outpatient and cancer care services Affidea has been awarded ‘Diagnostics provider of the year’ at the 2022 Health Investors Awards.

These awards recognise outstanding achievements, innovation and excellence in the independent healthcare sector and aim to reward organisations that have made a significant contribution in the medical sector.

Affidea was praised by the judges for its innovative approach in pioneering the latest technologies to improve clinical outcomes, patient safety and their experience in the medical centres, at the same time as driving operational efficiencies. Three initiatives drew the judges’ attention, including the digitisation of patients’ pathways across Affidea countries, from booking to eRegistration and eResults and the MRI Excellence programme that offers a live view of the utilisation of the MRI units and through which Affidea achieved a 28 per cent increase in examinations per hour.

Senior vp regional coo Michal Kwiecinski, who represented Affidea at the award ceremony at the Grosvenor House Hotel in London, stated: “It was an honour to receive the award on behalf of Affidea and our fantastic team of clinical, patient services and business professionals. We pride ourselves in providing the highest quality diagnostic imaging services across all 15 countries in which we operate. In the UK, through our group company Fortius Clinic, we offer a unique combination of high end diagnostics and world class orthopaedic surgery, enabling excellent clinical quality and an outstanding customer service for our patients.”

Picture: Affidea senior vp regional coo Michal Kwiecinski (centre) accepts the award on behalf of the whole company.

Published on page 4 of the August 2022 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more